# Reduce AAV Gene Therapy GMP Risks with Regulatory-Ready Titer Assays, Upcoming Webinar Hosted by Xtalks

- Source: PR Newswire M&A
- Published: 2026-11-05T13:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/reduce-aav-gene-therapy-gmp-risks-with-regulatory-ready-titer-assays-upcoming-webinar-hosted-by-xtalks-302929505.html
- Canonical: https://groundlevelnews.com/story/reduce-aav-gene-therapy-gmp-risks-with-regulatory-ready-titer-assays-u-e560e5/

In this free webinar, learn how AAV9 capsid titer assays can be validated for use in GMP-regulated quality control. The featured speakers will discuss validation requirements under ICH Q2 and Q14, including specificity, precision, accuracy, working range and system suitability. Attendees...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._